US Stock MarketDetailed Quotes

SYNAIRGEN (SYGGF)

Watchlist
  • 0.000100
  • 0.0000000.00%
15min DelayClose Mar 9 09:35 ET
110.27KMarket Cap0.00P/E (TTM)

About SYNAIRGEN Company

Synairgen Plc is a holding company, which engages in the provision of respiratory drug discovery and development. It focuses on severe asthma, chronic obstructive pulmonary disease, and severe viral infections. The company was founded by Donna E. Davies, Ratko Djukanovic, and Stephen T. Holgate in June 2003 and is headquartered in Southampton, the United Kingdom.

Company Profile

SymbolSYGGF
Company NameSYNAIRGEN
ISINGB00B0381Z20
Founded2004
CEOMr. Richard James Marsden
MarketPink Market
Employees34
Fiscal Year Ends12-31
AddressMailpoint 810,Southampton General Hospital,Tremona Road
CitySouthampton
ProvinceLondon & South East
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeSO16 6YD
Phone44-23-8051-2800
Websitehttp://www.synairgen.com

Company Executives

No Data

Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +22.01%
Sample Name
Sample Code
 +13.50%
Sample Name
Sample Code
 -5.72%
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
-9.06%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
-10.58%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.40%
Sample Name
Sample Code
 +12.56%
Sample Name
Sample Code
 +9.93%
4
Qifu Technology
QFIN
+9.25%
5
ASE Technology
ASX
+8.39%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On Tuesday, Trump stated that the United States and Iran had successfully signed a memorandum of understanding online, and that their negoti Show More
美伊和平曙光初現！全球市場「拆彈式狂歡」：誰在帶頭衝鋒，升势還能跑多遠？
After the U.S.-Iran memorandum of understanding, crude oil dropped 5%, and my first instinct was to check calls on airline stocks

- No more -